Finally, there might be a light at the end of the tunnel when it comes to ending peanut allergies. New research may have found the key to unlocking this mystery.
Fox News reports that an experimental treatment, in a phase 3 clinical trial, showed tremendous results and could become the first drug to protect those from exposure. Scientists used a capsule, called AR101,which is a capsule filled with a precise, but small measured quantity of peanut flour. Test subjects would have the contents of the capsule sprinkled on their food with the intent to build up a tolerance. Those who participated in the study were people who had a severe allergic reaction to a 10th of a peanut.
So, overtime, researchers mixed these capsules with their food in greater and greater quantities, hoping to prevent severe reactions from trace amounts of peanuts.
And, by the end of the trial, 67 percent of those who used the capsules were able to tolerate 2 peanuts, or a child sized bite of a peanut butter sandwich. This is huge considering 1.5 million to 2 million people under the age of 18 in the U.S. have a peanut allergy. So, the trial now hopes their peanut therapy will be approved by the end of the year with a European filing in 2019.
Currently, there’s no cure for a peanut allergy, but it looks like we are on the way of giving people peace of mind when it comes to accidental exposure.
Do you hope we see a cure for peanut allergies in the future?
Image credit: nilimage / iStock / Getty Images Plus / Getty